Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis

Published:2020-10-10 Issue:12 Volume:268 Page:4549-4562
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Siritho Sasitorn^ORCID,Nopsopon Tanawin^ORCID,Pongpirul Krit^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-020-10257-z.pdf

Reference32 articles.

1. Fujihara K, Misu T, Nakashima I, Takahashi T, Bradl M, Lassmann H (2012) Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease. Clin Exp Neuroimmunol 3:58–73

2. Ratelade J, Asavapanumas N, Ritchie AM, Wemlinger S, Bennett JL, Verkman AS (2013) Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelaination in a mouse model of neuromyelitis optica. Acta Neuropathol 126:699–709

3. Sharma R, Fischer M, Bauer J, Felts P, Smith K, Misu T (2010) Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol 120:223–236

4. Fukazawa T, Kikuchi S, Niino M et al (2004) Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders. J Neurol Sci 225:71–78

5. Wingerchuk D, Lennon V, Lucchinetti C, Pittock S, Weinshenker B (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805–815

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 32-year old lady who developed a complex generalized movement disorder in all four limbs after plasma exchange for myelitis;Parkinsonism & Related Disorders;2024-09

2. Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study;Journal of the Neurological Sciences;2024-07

3. New treatment options for Neuromyelitis optica spectrum disorders (NMOSD);Neurologie pro praxi;2024-06-20

4. Efgartigimod as rescue treatment in acute phase of neuromyelitis optica spectrum disorder: A Case Report;Heliyon;2024-05

5. Therapeutic Plasma Exchange Versus FcRn Inhibition in Autoimmune Disease;Transfusion Medicine Reviews;2024-01